Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT02086604 · COMPLETED
Trial details
- NCT number
- NCT02086604
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-18
- Primary completion
- 2017-06-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.